Resistant starch 30 g daily for 4 weeks in healthy adults was linked to less belly fat breakdown than placebo, but blood fat levels didn't change.
See the scientific wording
In healthy adults, 4 weeks of 30 g/day resistant starch supplementation is associated with lower nonesterified fatty acid (NEFA) release (P=0.02) and lower glycerol release (P=0.05) from subcutaneous abdominal adipose tissue compared with placebo, while systemic NEFA concentrations are not significantly altered. No absolute or relative effect sizes were reported.
Backed by science
Randomized trialsOne low-scoring study supports this claim, so treat this as an early signal rather than settled science.
What the research says
1 study reviewedSupporting (1)
Randomized Controlled TrialHuman2005
The study gave healthy adults 30 grams of resistant starch daily for 4 weeks and found less fat release from belly fat tissue, just like the claim says. The overall fat levels in the blood did not change significantly, also matching the claim.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Eating resistant starch sends it to the colon where gut bacteria break it into short-chain fatty acids. These acids enter the bloodstream and are taken up by belly fat tissue. Inside belly fat tissue, they reduce the breakdown of stored fat. This causes the belly fat tissue to release less fatty acids and glycerol. However, the total amount of fatty acids in the blood stays the same because other fat stores and the liver keep blood levels steady.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Resistant starch 30 g daily for 4 weeks in healthy adults was linked to less belly fat breakdown than placebo, but blood fat levels didn't change.
Mechanism
1 studyResistant starch travels to the colon where gut bacteria break it into short-chain fatty acids. These acids enter the blood and are taken up by belly fat. Inside belly fat, they reduce the breakdown of stored fat. So belly fat releases less fatty acids and glycerol. However, the total amount of fatty acids in the blood stays the same because other fat stores and the liver keep blood levels steady.
Eating resistant starch sends it to the colon where gut bacteria break it into short-chain fatty acids. These acids enter the bloodstream and are taken up by belly fat tissue. Inside belly fat tissue, they reduce the breakdown of stored fat. This causes the belly fat tissue to release less fatty acids and glycerol. However, the total amount of fatty acids in the blood stays the same because other fat stores and the liver keep blood levels steady.
Resistant starch escapes digestion in the small intestine and reaches the colon.
Colonic bacteria ferment resistant starch, producing short-chain fatty acids, mainly acetate and propionate.
Short-chain fatty acids enter the systemic circulation, increasing plasma acetate and propionate concentrations.
Adipose tissue takes up circulating acetate.
Acetate and other short-chain fatty acids signal inside adipocytes to suppress lipolysis.
Suppressed lipolysis reduces the release of nonesterified fatty acids and glycerol from subcutaneous abdominal adipose tissue.
Systemic nonesterified fatty acid concentrations remain unchanged despite reduced release from subcutaneous abdominal adipose tissue.
Nonesterified fatty acids released from other adipose depots and hepatic clearance maintain systemic concentrations, compensating for the reduced subcutaneous abdominal adipose tissue release.
Evidence from Studies
Supporting (1)
Community contributions welcome
Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism.
The study gave healthy adults 30 grams of resistant starch daily for 4 weeks and found less fat release from belly fat tissue, just like the claim says. The overall fat levels in the blood did not change significantly, also matching the claim.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Resistant Starch Supplementation and Adipose Tissue Lipolysis in Healthy Adults
Systematic search and meta-analysis of randomized placebo-controlled trials in healthy adults, with 30 g/day resistant starch for ≥4 weeks, measuring NEFA and glycerol release from subcutaneous abdominal adipose tissue and systemic NEFA.
Double-Blind Randomized Controlled Trial of 30 g/day Resistant Starch vs Placebo for 4 Weeks on Subcutaneous Abdominal Adipose Tissue NEFA and Glycerol Release in Healthy Adults
Double-blind, placebo-controlled RCT in healthy adults randomized to 30 g/day resistant starch or placebo for 4 weeks; primary outcomes: NEFA and glycerol release from subcutaneous abdominal adipose tissue; secondary outcome: systemic NEFA concentrations.
Prospective Cohort Study of Habitual Resistant Starch Intake and Adipose Tissue Lipolysis Markers in Healthy Adults
Prospective cohort of healthy adults with dietary assessment of resistant starch intake, followed for ≥4 weeks, measuring NEFA and glycerol release from subcutaneous abdominal adipose tissue and systemic NEFA.
Cross-Sectional Study of Resistant Starch Consumption and NEFA/Glycerol Release from Subcutaneous Abdominal Adipose Tissue in Healthy Adults
Cross-sectional study measuring resistant starch intake and adipose tissue NEFA/glycerol release in healthy adults; adjusts for confounders.
In Vitro Study of Resistant Starch Fermentation Products on Lipolysis in Human Subcutaneous Abdominal Adipocytes
In vitro culture of human subcutaneous abdominal adipocytes treated with resistant starch fermentation metabolites (e.g., short-chain fatty acids) and measured for NEFA and glycerol release.